Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamoxifen and Raloxifene effects on cognitive aging
NCT00687102Phase 3Completed
- Sponsor
- Wake Forest University
- Start
- Oct 2001
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in breast cancer comparing Tamoxifen with Raloxifene (2 arms). Primary endpoints: Benton Visual Retention Test at 3 years and California Verbal Learning Test at 3 years. Started Oct 2001; status: completed.
02
Drugs
tamoxifenraloxifene
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00687102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00687102.